Lung Transplant Rejection: Clinical Trials

3 trials for Lung Transplant Rejection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Recruiting 1

Follow Lung Transplant Rejection: new trials by email Literature Review of Lung Transplant Rejection trials Research Report on Lung Transplant Rejection

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
Belumosudil, Azithromycin, Placebo - Lung Transplant Rejection
Phase 3RecruitingSanofi1802023-10-102026-10-28
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)
Liposomal Cyclosporine A, standard of care - Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant
Phase 3CompletedZambon SpA622019-03-262025-10-27
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
Liposomal Cyclosporine A, Standard of Care - Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant
Phase 3CompletedZambon SpA1692019-03-262026-02-10

Narrower conditions

Bronchiolitis Obliterans (2)  ·  Rejection, Psychology (2)

Broader conditions

Behavior (2)  ·  Bronchial Diseases (2)  ·  Bronchiolitis (2)  ·  Bronchitis (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Obstructive (2)  ·  Respiratory Tract Diseases (2)  ·  Social Behavior (2)

Interventions

Standard of Care (2)  ·  Azithromycin (1)  ·  belumosudil (1)

Sponsors

Zambon SpA (2)  ·  Sanofi (1)

Countries

Belgium (3)  ·  France (3)  ·  Germany (3)  ·  Israel (3)  ·  Spain (3)  ·  United States (3)  ·  Austria (2)  ·  Denmark (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Finland (1)  ·  Hungary (1)

Top investigators

Paola Castellani, MD (2)

NIH funding

2018 (2), 2023 (1)